The company’s board of directors approved an increase to its 2025 share repurchase program authorization, from $500M to $1B. This program has no specified expiration date.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health sees Q4 adjusted EPS 46c-49c, consensus 46c
- 3 Strong Buy Stocks with a ‘Perfect 10’ Smart Score Right Now
- Stephens starts Option Care Health at Overweight based on value chain position
- Option Care Health initiated with an Overweight at Stephens
- Option Care Health price target raised to $35 from $32 at BofA